SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrigin Regulatory News (OGN)

Share Price Information for Origin (OGN)

Share Price is delayed by 15 minutes
Get Live Data
397.50    0.00 (0.00%)
Bid:
385.00
Ask:
410.00
Spread: 25.00 (6.494%)
Market Cap: £427.26m
OGN Live PriceLast checked at - London Stock Exchange

Intraday Origin Share Chart

Directorate Changes

29 Sep 2022 07:00

RNS Number : 0756B
Origin Enterprises Plc
29 September 2022
 
Origin Enterprises plc

 

Appointment of Non-Executive Director and Board Committee Changes

 

Alan Ralph joins Origin as an independent Director

 

Dublin, London, 29 September 2022: Origin Enterprises plc ('Origin' or 'the Group'), the international Agronomy-Services Group providing specialist advice, inputs and digital solutions to promote sustainable land use, is pleased to announce the appointment of Mr Alan Ralph to the Board as an independent Non-Executive Director, with effect from 3 October 2022. Origin also announces Senior Independent Director and Board Committee changes, which will take effect following the conclusion of the Company's Annual General Meeting ('AGM') on 22 November 2022.

 

New independent Non-Executive Director

Alan Ralph (53) is a highly experienced business professional and financial leader having spent 20 years with UDG Healthcare plc. He spent 10 years leading UDG's largest business unit before supporting the company's strategic transformation as Chief Financial Officer for five years. Alan is a Fellow of Chartered Accountants Ireland and previously worked in Banta Corporation and PwC. 

 

Alan was nominated to the Board following a thorough recruitment process led by the Nomination and Corporate Governance Committee. He also currently serves as a Non-Executive Director of DCC plc and is Chair of their Audit Committee.

 

As of today, Alan holds interests in 10,000 Ordinary Shares of Origin, representing approximately 0.009% of the Company's issued share capital, excluding treasury shares. 

 

Senior Independent Director and Board Committee Changes

In June 2022, the Group announced that Gary Britton was appointed Chair Designate to succeed Rose Hynes at the 2022 AGM. At that time, he will also assume the role of Chair of the Nomination and Corporate Governance Committee and join the Remuneration Committee as a member. Alan Ralph will become Chair of the Audit and Risk Committee and a member of the Nomination and Corporate Governance Committee.

 

Helen Kirkpatrick has been appointed as Origin's Senior Independent Director to replace Gary Britton at the conclusion of the AGM, when she will also step down as a member of the ESG Committee. The ESG Committee membership otherwise remains consistent, with Lesley Williams in the role of Chair of the Committee since 1 August 2022.

 

Rose Hynes, Chairman of Origin, commented:

"As part of our ongoing evaluation of Board composition and in planning for Gary Britton to transition into the role of Chairman following the AGM in November 2022, we are pleased to provide an update on a number of Board positions. We undertook a comprehensive recruitment process for the appointment of a new Non-Executive Director, culminating in the appointment of Alan Ralph. I am delighted to welcome Alan to the Board and look forward to the contribution his financial expertise and extensive business experience will provide Origin through its next phase of growth and development.

 

Helen Kirkpatrick has been appointed as the Company's new Senior Independent Director in line with our succession planning and our Committee memberships will be refreshed to reflect the skillsets and experience of the Board as a whole."

 

The following information in respect of Alan Ralph is disclosed pursuant to Rule 17 of the AIM Rules for Companies:

 

Current Directorships: 

DCC plc

Killarney Glen Owners Management Company Limited by Guarantee

 

Directorships held in the last 5 years:

Aquilant Limited

Aquilant Scientific (ROI) Limited

Ashfield Alliance Limited

Dublin Drug (Investments) Limited

Dublin Drug Company Limited

Dublin Drug Public Limited Company

UDG Healthcare (US) Holdings Limited

UDG Healthcare Ayrtons (Dublin) Limited

UDG Healthcare Finance Limited

UDG Healthcare Ireland Limited

UDG Healthcare plc

UDG Healthcare Nordic Limited

UDG Healthcare Property Holdings Limited

United Care Limited

 

 

ENDS

 

There is no other information that is required to be disclosed in accordance with Rule 17, Schedule 2 paragraph (g) of the AIM Rules for Companies.

 

Enquiries

 

Origin Enterprises plc

TJ Kelly

Chief Financial Officer

 

Tel:

+353 (0)1 563 4959

 

Brendan Corcoran

Head of Investor Relations and Group Planning

 

Tel:

 

+353 (0)1 563 4900

 

Goodbody (Euronext Growth (Dublin) Adviser)

Finbarr Griffin

 

Tel:

 

+353 (0)1 641 9278

 

Davy (Nominated Adviser) Anthony Farrell

 

Tel:

 

+353 (0)1 614 9993

 

Numis Securities (Stockbroker) Stuart Skinner

 

Tel:

 

+44 (0)20 7260 1314

 

FTI Consulting (Financial Communications Advisers) Jonathan Neilan/ Patrick Berkery

 

Tel:

 

+353 (0)1 765 0884

About Origin Enterprises plc

 

Origin Enterprises plc is an international Agronomy-Services group, providing specialist advice, inputs, services and digital solutions to promote sustainable land use. The Group has leading market positions in Ireland, the United Kingdom, Brazil, Poland, Romania and Ukraine. Origin is listed on the Euronext Growth (Dublin) and AIM markets of the Irish and London Stock Exchanges.

 

Euronext Growth (Dublin) ticker symbol:

OIZ

AIM ticker symbol:

OGN

Website:

www.originenterprises.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFZGZLRRRGZZM
Date   Source Headline
3rd Oct 202511:26 amRNSRe-issue of Treasury Shares
2nd Oct 20252:45 pmRNSRe-issue of Treasury Shares
1st Oct 20251:11 pmRNSRe-issue of Treasury Shares
1st Oct 20257:00 amRNSDirectorate Change
30th Sep 20252:58 pmRNSRe-issue of Treasury Shares
25th Sep 20254:02 pmRNSHolding(s) in Company
25th Sep 20254:02 pmRNSHolding(s) in Company
24th Sep 202510:00 amRNSDirector/PDMR Shareholding
24th Sep 202510:00 amRNSDirector/PDMR Shareholding
24th Sep 202510:00 amRNSDirector/PDMR Shareholding
23rd Sep 20257:00 amRNSFinal Results
22nd Sep 20254:49 pmRNSRe-issue of Treasury Shares
26th Aug 20257:00 amRNSHolding(s) in Company
13th Aug 20255:11 pmRNSHolding(s) in Company
30th Jul 20254:31 pmRNSHolding(s) in Company
26th Jun 202511:23 amRNSCancellation of Treasury Shares
20th Jun 202512:27 pmRNSRe-issue of Treasury Shares
18th Jun 202512:51 pmRNSDirector/PDMR Shareholding
13th Jun 20255:09 pmRNSRe-issue of Treasury Shares
13th Jun 20253:00 pmRNSDirector/PDMR Shareholding
12th Jun 20257:00 amRNSQ3 Trading Update
28th May 20254:18 pmRNSHolding(s) in Company
22nd May 20257:00 amRNSHolding(s) in Company
2nd May 20257:00 amRNSBlock Listing Six Monthly Return
29th Apr 20251:41 pmRNSDirector/PDMR Shareholding
29th Apr 20251:33 pmRNSDirector/PDMR Shareholding
29th Apr 20251:32 pmRNSDirector/PDMR Shareholding
24th Apr 20252:58 pmRNSHolding(s) in Company
9th Apr 202511:44 amRNSHolding(s) in Company
4th Apr 20253:34 pmRNSHolding(s) in Company
2nd Apr 20251:53 pmRNSHolding(s) in Company
25th Mar 20254:54 pmRNSHolding(s) in Company
4th Mar 20257:00 amRNSInterim Results Statement
28th Feb 20255:19 pmRNSHolding(s) in Company
26th Feb 20251:13 pmRNSHolding(s) in Company
25th Feb 20253:51 pmRNSHolding(s) in Company
17th Feb 20257:00 amRNSNew five-year €440 million credit facility
5th Feb 20256:12 pmRNSHolding(s) in Company
4th Feb 202511:52 amRNSRe-issue of Treasury Shares
31st Jan 20255:22 pmRNSLong Term Incentive Plan / PDMR Notification
31st Jan 20253:05 pmRNSRe-issue of Treasury Shares
30th Jan 20256:08 pmRNSDirector/PDMR Shareholding
30th Jan 20256:05 pmRNSLong Term Incentive Plan / PDMR Notification
27th Jan 20252:52 pmRNSDirector/PDMR Shareholding
23rd Jan 20253:15 pmRNSHolding(s) in Company
22nd Jan 20257:00 amRNSDirector/PDMR Shareholding
20th Jan 20252:14 pmRNSHolding(s) in Company
16th Jan 20255:13 pmRNSHolding(s) in Company
7th Jan 20252:55 pmRNSDirector/PDMR Shareholding
12th Dec 20242:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.